CDKN2A and cancer: Cell cycle typically relies on Cyclins and Cyclin-Dependent Kinases (CDKs), as well as on their functional control by CDK Inhibitors (CDKIs: KIP/CIP and INK4 protein families), to drive the progression through its phases; molecular processes that are usually disrupted in cancer [51,52].